Banco Santander, S.A. has announced the removal of its Series SP-199 6.527% Senior Preferred Callable Fixed-to-Fixed Rate Notes from the New York Stock Exchange (NYSE). This decision is part of a broader strategy to streamline its financial operations and reflects ongoing adjustments within the commercial banking sector.
The delisting will take effect on November 20, 2026, following the redemption of the securities on November 7, 2026. The NYSE has notified the Securities and Exchange Commission (SEC) of this change, stating that the entire class of the stated securities was called for redemption, and funds for their payment were deposited with an authorized agency.
Background
Banco Santander, S.A. is a prominent player in the financial services industry, classified under the SIC code 6029, which stands for Commercial Banks, NEC. The company is listed on the NYSE under the ticker symbol SAN and also trades on the OTC market under BCDRF. As a large accelerated filer, Banco Santander is subject to stringent reporting requirements, ensuring transparency and accountability in its operations.
What the Filing Says
The SEC filing, accession number 0000876661-26-000902, details that the NYSE intends to remove the Series SP-199 notes from listing and registration due to their redemption. The filing states, "The entire class of this security was called for redemption... and such funds were made available to security holders on November 09, 2026." This indicates that the company has fulfilled its obligations to the noteholders.
Impact
This decision may affect investors holding these preferred notes, as they will no longer be able to trade them on the NYSE after the delisting. Additionally, the removal of these securities could signify a shift in Banco Santander's capital structure or financial strategy, which may have implications for its overall market position.
What's Next
The filing does not say what happens next regarding Banco Santander's other securities or potential future offerings. Investors and market analysts will be closely watching for any further announcements from the company.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










